Lemon Healthcare CEO Byungjin Hong Reports 27.42% Stake After Listing

Lemon Healthcare CEO Byungjin Hong reported acquiring 3,661,015 common shares on July 6, 2026 due to the initial listing, resulting in a 27.42% stake.
This is the first insider ownership report after listing, officially confirming the CEO's shareholding out of 13,351,559 total outstanding shares.
The reported change is a routine registration from the new listing, with no additional capital raising or dilution impact on shareholder value.
[AI Summary]This filing is a procedural disclosure confirming the CEO's existing stake after listing. There is no capital change or dilution effect, and it has limited direct relevance to financial performance or growth strategy. The impact on stock price is assessed as neutral.